IDEX Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

IDEX wird ein jährliches Gewinn- und Umsatzwachstum von 14.6% bzw. 8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.6% betragen.

Wichtige Informationen

14.6%

Wachstumsrate der Gewinne

14.5%

EPS-Wachstumsrate

Machinery Gewinnwachstum	8.7%
Wachstumsrate der Einnahmen	8.0%
Zukünftige Eigenkapitalrendite	17.6%
Analystenabdeckung	Good
Zuletzt aktualisiert	04 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

IDEX Corporation (NYSE:IEX) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Recent updates

IDEX Corporation (NYSE:IEX) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Is IDEX Corporation (NYSE:IEX) Trading At A 39% Discount?

Jul 16

IDEX Corp.: There Are Better Opportunities Out There

Jul 11

Is Now An Opportune Moment To Examine IDEX Corporation (NYSE:IEX)?

Jul 01

IDEX: Order Moderation Illuminating A Path Forward

Jun 30

Here's Why IDEX (NYSE:IEX) Can Manage Its Debt Responsibly

Jun 15

Ensemble Capital - IDEX Corp: A Mundane Company Ready To Fire On All Cylinders

Apr 20

IDEX Corporation's (NYSE:IEX) Share Price Could Signal Some Risk

Apr 11

Is There Now An Opportunity In IDEX Corporation (NYSE:IEX)?

Mar 27

IDEX Corporation (NYSE:IEX) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 12

Here's Why IDEX (NYSE:IEX) Can Manage Its Debt Responsibly

Feb 05

If EPS Growth Is Important To You, IDEX (NYSE:IEX) Presents An Opportunity

Jan 23

IDEX Corporation: A Great Compounder For 2024

Dec 27

IDEX Corporation's (NYSE:IEX) Shares May Have Run Too Fast Too Soon

Dec 27

Returns On Capital At IDEX (NYSE:IEX) Have Stalled

Dec 14

Is Now An Opportune Moment To Examine IDEX Corporation (NYSE:IEX)?

Nov 30

IDEX Corporation: Long-Term Value Creator Is Struggling Here

Nov 21

Calculating The Fair Value Of IDEX Corporation (NYSE:IEX)

Nov 17

IDEX: Recovery Into FY24, Except Health & Science Technologies; Maintain 'Buy'

Nov 06

Concerns Surrounding IDEX's (NYSE:IEX) Performance

Nov 02

We Think IDEX (NYSE:IEX) Can Stay On Top Of Its Debt

Oct 27

IDEX: Current Health And Science Segment Weakness Creates A Good Entry Point

Oct 06

Should You Be Adding IDEX (NYSE:IEX) To Your Watchlist Today?

Sep 29

IDEX (NYSE:IEX) Has Some Way To Go To Become A Multi-Bagger

Sep 14

Is Now The Time To Look At Buying IDEX Corporation (NYSE:IEX)?

Aug 30

IDEX: Slow And Steady Wins The Race

Aug 17

Estimating The Fair Value Of IDEX Corporation (NYSE:IEX)

Aug 15

IDEX (NYSE:IEX) Could Easily Take On More Debt

Jul 17

Here's Why We Think IDEX (NYSE:IEX) Is Well Worth Watching

Jun 26

IDEX Corporation: Dealmaking Machine At Work

Jun 02

Should You Investigate IDEX Corporation (NYSE:IEX) At US$203?

May 28

Calculating The Intrinsic Value Of IDEX Corporation (NYSE:IEX)

May 15

IDEX (NYSE:IEX) Has A Rock Solid Balance Sheet

Apr 16

Investors Met With Slowing Returns on Capital At IDEX (NYSE:IEX)

Apr 02

If EPS Growth Is Important To You, IDEX (NYSE:IEX) Presents An Opportunity

Mar 19

What Is IDEX Corporation's (NYSE:IEX) Share Price Doing?

Feb 19

Calculating The Intrinsic Value Of IDEX Corporation (NYSE:IEX)

Feb 05

IDEX Q4 2022 Earnings Preview

Jan 31

Is IDEX (NYSE:IEX) A Risky Investment?

Jan 05

Returns At IDEX (NYSE:IEX) Appear To Be Weighed Down

Dec 21

IDEX Rightly Appreciated For Its Excellent Credentials And Advantageous Market Exposures

Dec 12

IDEX declares $0.60 dividend

Nov 09

Should You Think About Buying IDEX Corporation (NYSE:IEX) Now?

Nov 08

Gewinn- und Umsatzwachstumsprognosen

NYSE:IEX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,759	654	731	820	7
12/31/2025	3,520	562	687	724	13
12/31/2024	3,278	512	606	690	11
9/30/2024	3,195	490	625	697	N/A
6/30/2024	3,190	580	640	718	N/A
3/31/2024	3,229	578	642	725	N/A
12/31/2023	3,274	596	627	717	N/A
9/30/2023	3,296	618	595	683	N/A
6/30/2023	3,326	587	570	655	N/A
3/31/2023	3,276	587	547	626	N/A
12/31/2022	3,182	587	489	557	N/A
9/30/2022	3,086	576	478	553	N/A
6/30/2022	2,974	513	438	512	N/A
3/31/2022	2,864	477	462	536	N/A
12/31/2021	2,765	449	493	565	N/A
9/30/2021	2,665	432	506	564	N/A
6/30/2021	2,534	420	500	561	N/A
3/31/2021	2,409	389	540	594	N/A
12/31/2020	2,352	378	518	569	N/A
9/30/2020	2,343	374	505	559	N/A
6/30/2020	2,386	375	516	562	N/A
3/31/2020	2,467	417	473	524	N/A
12/31/2019	2,495	426	477	528	N/A
9/30/2019	2,503	427	477	530	N/A
6/30/2019	2,501	428	446	507	N/A
3/31/2019	2,494	422	433	496	N/A
12/31/2018	2,484	411	419	479	N/A
9/30/2018	2,455	406	402	462	N/A
6/30/2018	2,407	384	N/A	453	N/A
3/31/2018	2,346	360	N/A	420	N/A
12/31/2017	2,287	337	N/A	433	N/A
9/30/2017	2,232	301	N/A	412	N/A
6/30/2017	2,188	287	N/A	414	N/A
3/31/2017	2,164	279	N/A	415	N/A
12/31/2016	2,113	271	N/A	400	N/A
9/30/2016	2,082	281	N/A	383	N/A
6/30/2016	2,056	290	N/A	371	N/A
3/31/2016	2,021	284	N/A	381	N/A
12/31/2015	2,021	283	N/A	360	N/A
9/30/2015	2,045	277	N/A	363	N/A
6/30/2015	2,074	268	N/A	350	N/A
3/31/2015	2,106	270	N/A	343	N/A
12/31/2014	2,148	278	N/A	368	N/A
9/30/2014	2,144	284	N/A	368	N/A
6/30/2014	2,102	276	N/A	386	N/A
3/31/2014	2,074	267	N/A	404	N/A
12/31/2013	2,024	254	N/A	402	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: IEXDas prognostizierte Gewinnwachstum (14.6% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: IEXDie Erträge des Unternehmens (14.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.5% pro Jahr).

Hohe Wachstumserträge: IEXDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: IEXDie Einnahmen des Unternehmens (8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).

Hohe Wachstumseinnahmen: IEXDie Einnahmen des Unternehmens (8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: IEXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17.6%).

IDEX Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

IDEX Corporation Revises Earnings Guidance for the Full Year of 2024

IDEX Corporation (NYSE:IEX) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

IDEX Corporation Provides Earnings Guidance for the Third Quarter of 2024

IDEX Corporation Provides Earnings Guidance for the Second Quarter of 2024 and Full Year 2024

IDEX Corporation Provides Earnings Guidance for the First Quarter of 2024 and Full Year of 2024

Consensus EPS estimates increase by 13%

Recent updates

IDEX Corporation Declares Regular Quarterly Cash Dividend, Payable on January 31, 2025

IDEX Corporation: A Demanding Valuation For A Great Business

IDEX Corporation Revises Earnings Guidance for the Full Year of 2024

Are Investors Undervaluing IDEX Corporation (NYSE:IEX) By 31%?

What Is IDEX Corporation's (NYSE:IEX) Share Price Doing?

Upcoming dividend of US$0.69 per share

IDEX Corporation's (NYSE:IEX) Shares May Have Run Too Fast Too Soon

Second quarter dividend of US$0.69 announced

IDEX Corporation Declares Regular Quarterly Cash Dividend, Payable on October 25, 2024

IDEX Corporation (NYSE:IEX) completed the acquisition of Mott Corporation.

IDEX Corp. Q2: Project Delay And Weakness In Life Science

Capital Allocation Trends At IDEX (NYSE:IEX) Aren't Ideal

IDEX Corporation (NYSE:IEX) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Second quarter 2024 earnings: EPS in line with expectations, revenues disappoint

IDEX Corporation Provides Earnings Guidance for the Third Quarter of 2024

IDEX Corporation (NYSE:IEX) entered into an agreement to acquire Mott Corporation for $1 billion.

Is IDEX Corporation (NYSE:IEX) Trading At A 39% Discount?

IDEX Corp.: There Are Better Opportunities Out There

Upcoming dividend of US$0.69 per share

Is Now An Opportune Moment To Examine IDEX Corporation (NYSE:IEX)?

IDEX: Order Moderation Illuminating A Path Forward

Dividend of US$0.69 announced

IDEX Corporation Declares Regular Quarterly Cash Dividend, Payable on July 26, 2024

Here's Why IDEX (NYSE:IEX) Can Manage Its Debt Responsibly

Interpump Group S.p.A. (BIT:IP) acquired Alfa Valvole Srl from IDEX Corporation (NYSE:IEX) for €55.2 million.

IDEX Corporation Approves Regular Quarterly Cash Dividend, Payable on May 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations

IDEX Corporation Provides Earnings Guidance for the Second Quarter of 2024 and Full Year 2024

Ensemble Capital - IDEX Corp: A Mundane Company Ready To Fire On All Cylinders

IDEX Corporation's (NYSE:IEX) Share Price Could Signal Some Risk

IDEX Corporation, Annual General Meeting, May 07, 2024

Is There Now An Opportunity In IDEX Corporation (NYSE:IEX)?

IDEX Corporation (NYSE:IEX) Shares Could Be 23% Below Their Intrinsic Value Estimate

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

IDEX Corporation Provides Earnings Guidance for the First Quarter of 2024 and Full Year of 2024

Here's Why IDEX (NYSE:IEX) Can Manage Its Debt Responsibly

If EPS Growth Is Important To You, IDEX (NYSE:IEX) Presents An Opportunity

IDEX Corporation: A Great Compounder For 2024

IDEX Corporation's (NYSE:IEX) Shares May Have Run Too Fast Too Soon

IDEX Corporation (NYSE:IEX) completed the acquisition of Superior Technical Ceramics Corp. from Artemis Capital Partners II, L.P., managed by Artemis Capital Partners Management Co., LLC for approximately $210 million.

Returns On Capital At IDEX (NYSE:IEX) Have Stalled

Is Now An Opportune Moment To Examine IDEX Corporation (NYSE:IEX)?

IDEX Corporation: Long-Term Value Creator Is Struggling Here

Calculating The Fair Value Of IDEX Corporation (NYSE:IEX)

IDEX Corporation Declares Regular Quarterly Cash Dividend, Payable on January 26, 2024

IDEX: Recovery Into FY24, Except Health & Science Technologies; Maintain 'Buy'

Concerns Surrounding IDEX's (NYSE:IEX) Performance

Consensus EPS estimates increase by 13%

IDEX Corporation Names Abhi Khandelwal as Senior Vice President, Effective November 20, 2023

We Think IDEX (NYSE:IEX) Can Stay On Top Of Its Debt

Third quarter 2023 earnings: EPS exceeds analyst expectations

IDEX Corporation Provides Earnings Guidance for the Fourth Quarter of 2023

Now 20% undervalued after recent price drop

IDEX: Current Health And Science Segment Weakness Creates A Good Entry Point

Upcoming dividend of US$0.64 per share at 1.2% yield

Should You Be Adding IDEX (NYSE:IEX) To Your Watchlist Today?

IDEX (NYSE:IEX) Has Some Way To Go To Become A Multi-Bagger

IDEX Corporation Declares Regular Quarterly Cash Dividend, Payable on October 27, 2023

IDEX Corporation Announces CFO Changes, Effective on September 15, 2023

Is Now The Time To Look At Buying IDEX Corporation (NYSE:IEX)?

IDEX: Slow And Steady Wins The Race

Estimating The Fair Value Of IDEX Corporation (NYSE:IEX)

IDEX Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

IDEX (NYSE:IEX) Could Easily Take On More Debt

Upcoming dividend of US$0.64 per share at 1.2% yield

Here's Why We Think IDEX (NYSE:IEX) Is Well Worth Watching

IDEX Corporation Approves Regular Quarterly Cash Dividend, Payable on July 28, 2023

IDEX Corporation announced that it has received $100 million in funding

IDEX Corporation: Dealmaking Machine At Work